Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan

References

• Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246–55.
   PubMed Web of Science ®Google Scholar
• Silman AJ. Scleroderma – demographics and survival. J Rheumatol Suppl 1997;48:58–61.
   PubMedGoogle Scholar
• Karassa FB, Ioannidis JP. Mortality in systemic sclerosis. Clin Exp Rheumatol 2008;26(Suppl 51):S85–93.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2–10.
   PubMed Web of Science ®Google Scholar
• Hesselstrand R, Wildt M, Ekmehag B, Wuttge D, Scheja A. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol 2010, [Epub ahead of print], DOI 10.3109/03009742.2010.508751
   Web of Science ®Google Scholar
• Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Scleroderma renal crisis: patient characteristics and long-term outcomes. Q J Med 2007;100:485–94.
   Google Scholar
• Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002;81:154–67.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 2007;66:940–4.
   PubMed Web of Science ®Google Scholar
• Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139–53.
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Lee P. Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 1995;22:2100–2.
   PubMed Web of Science ®Google Scholar
• Bryan C, Howard Y, Brennan P, Black C, Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996;35:1122–6.
   PubMedGoogle Scholar
• Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998;37:750–5.
   PubMedGoogle Scholar
• Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682–6.
   PubMed Web of Science ®Google Scholar
• Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 2003;42:71–5.
   PubMed Web of Science ®Google Scholar
• Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K, Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 1996;23:677–82.
   Google Scholar
• Lu TH, Shau WY, Shih TP, Lee MC, Chou MC, Lin CK. Factors associated with errors in death certificate completion. A national study in Taiwan. J Clin Epidemiol 2001;54:232–8.
   PubMed Web of Science ®Google Scholar
• Lu TH, Lee MC, Chou MC. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 2000;29:336–43.
   PubMed Web of Science ®Google Scholar
• Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131:373–5.
   PubMed Web of Science ®Google Scholar
• Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 2005;34:714–20.
   PubMed Web of Science ®Google Scholar
• Mayes MD. Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 1997;9:557–61.
   PubMedGoogle Scholar
• Steen VD, Medsger TA Jr. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 1990;16:1–10.
   PubMed Web of Science ®Google Scholar
• Medsger TA Jr, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971;74:714–21.
   PubMed Web of Science ®Google Scholar
• Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991; 283:366–71.
   PubMed Web of Science ®Google Scholar
• Black CM, Myers AR. Systemic sclerosis (scleroderma): current topics in rheumatology. New York: Gower Medical Publishing, 1985.
   Google Scholar
• Kurland LT, Hauser WA, Ferguson RH, Holley KE. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969;44:649–63.
   PubMed Web of Science ®Google Scholar
• Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 1996;22:751–64.
   PubMed Web of Science ®Google Scholar
• Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998–1006.
   PubMed Web of Science ®Google Scholar
• Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37:223–35.
   PubMed Web of Science ®Google Scholar
• Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 1997;40:441–5.
   PubMed Web of Science ®Google Scholar
• Arias-Nunez MC, Llorca J, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Martin J, Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine (Baltimore) 2008;87:272–80.
   PubMed Web of Science ®Google Scholar
• Hudson M, Thombs B, Baron M. Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum 2009;61:274–8.
   PubMed Web of Science ®Google Scholar
• Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z, Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67: 59–63.
   PubMed Web of Science ®Google Scholar
• Lee P, Alderdice C, Wilkinson S, Keystone EC, Urowitz MB, Gladman DD. Malignancy in progressive systemic sclerosis – association with breast carcinoma. J Rheumatol 1983;10:665–6.
   PubMed Web of Science ®Google Scholar
• Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28:1336–40.
   PubMed Web of Science ®Google Scholar
• Young R, Towbin B, Isern R. Scleroderma and ovarian carcinoma. Br J Rheumatol 1990;29:314.
   PubMedGoogle Scholar
• Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369–76.
   Google Scholar
• Wynn J, Fineberg N, Matzer L, Cortada X, Armstrong W, Dillon JC, Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 1985;110:123–7.
   PubMed Web of Science ®Google Scholar
• Medsger TA Jr, Masi AT. Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis 1973;26:647–60.
   Google Scholar